Drug-associated acute lung injury: A population-based cohort study

Chest

Volumn 142, Issue 4, 2012, Pages 845-850

  Dhokarh, Rajanigandha ^a,b   Li, Guangxi ^a,c   Schmickl, Christopher N ^a,d   Kashyap, Rahul ^a   Assudani, Jyoti ^a   Limper, Andrew H ^a   Gajic, Ognjen ^a  

^a MAYO CLINIC   (United States)

^b LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^c INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^d UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; ARSENIC TRIOXIDE; BASILIXIMAB; BLEOMYCIN; BUSULFAN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; DOCETAXEL; DOXORUBICIN; FLUDARABINE; GEFITINIB; GEMCITABINE; INFLIXIMAB; IRINOTECAN; MELPHALAN; METHOTREXATE; MITOMYCIN C; NITROFURANTOIN; OXALIPLATIN; PACLITAXEL; PENTOSTATIN; RETINOIC ACID; RITUXIMAB; TENIPOSIDE; UNINDEXED DRUG; VINBLASTINE;

ACUTE LUNG INJURY; ADULT; AGED; APACHE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DISEASE COURSE; DRUG EXPOSURE; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; UNITED STATES;

EID: 84867128813     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-2103     Document Type: Article

References (23)

1. Lee-Chiong T Jr, Matthay RA. Drug-induced pulmonary edema and acute respiratory distress syndrome. Clin Chest Med. 2004;25(1):95-104. (Pubitemid 38296335)
2. Dimopoulou I, Bamias A, Lyberopoulos P, Dimopoulos MA. Pulmonary toxicity from novel antineoplastic agents. Ann Oncol. 2006;17(3):372-379. (Pubitemid 43329572)
3. Cooper JA Jr, White DA, Matthay RA. Drug-induced pulmonary disease. Part 1: cytotoxic drugs. Am Rev Respir Dis. 1986;133(2):321-340. (Pubitemid 16123932)
4. Reed CR, Glauser FL. Drug-induced noncardiogenic pulmonary edema. Chest. 1991;100(4):1120-1124.
5. Rosenow EC III, Myers JL, Swensen SJ, Pisani RJ. Drug-induced pulmonary disease. An update. Chest. 1992;102(1):239-250.
6. Limper AH. Chemotherapy-induced lung disease. Clin Chest Med. 2004;25(1):53-64. (Pubitemid 38296331)
7. Rosenow EC III, Limper AH. Drug-induced pulmonary disease. Semin Respir Infect. 1995;10(2):86-95.
8. Cooper JA Jr, White DA, Matthay RA. Drug-induced pulmonary disease. Part 2: noncytotoxic drugs. Am Rev Respir Dis. 1986;133(3):488-505. (Pubitemid 16126287)
9. Pneumotox on line. The drug-induced lung diseases. http://www.pneumotox. com. Accessed August 2, 2011.
10. Irey NS. Teaching monograph. Tissue reactions to drugs. Am J Pathol. 1976;82(3):613-647.
11. Silva CI, Müller NL. Drug-induced lung diseases: most common reaction patterns and corresponding high-resolution CT manifestations. Semin Ultrasound CT MR. 2006;27(2):111-116.
12. Cooper JA Jr, Matthay RA. Drug-induced pulmonary disease. Dis Mon. 1987;33(2):61-120. (Pubitemid 17025760)
13. Erasmus JJ, McAdams HP, Rossi SE. Drug-induced lung injury. Semin Roentgenol. 2002;37(1):72-81.
14. Leaver SK, Evans TW. Acute respiratory distress syndrome. BMJ. 2007;335(7616):389-394. (Pubitemid 47359318)
15. Li G, Malinchoc M, Cartin-Ceba R, et al. Eight-year trend of acute respiratory distress syndrome: a population-based study in Olmsted County, Minnesota. Am J Respir Crit Care Med. 2011;183(1):59-66.
16. Herasevich V, Yilmaz M, Khan H, Hubmayr RD, Gajic O. Validation of an electronic surveillance system for acute lung injury. Intensive Care Med. 2009;35(6):1018-1023.
17. Bernard GR, Artigas A, Brigham KL, et alConsensus Committee. Report of the American-European Consensus conference on acute respiratory distress syndrome: definitions, mechanisms, relevant outcomes, and clinical trial coordination. J Crit Care. 1994;9(1):72-81. (Pubitemid 24095051)
18. Parambil JG, Myers JL, Aubry MC, Ryu JH. Causes and prognosis of diffuse alveolar damage diagnosed on surgical lung biopsy. Chest. 2007;132(1):50-57. (Pubitemid 47068202)
19. Van Mieghem W, Coolen L, Malysse I, Lacquet LM, Deneffe GJ, Demedts MG. Amiodarone and the development of ARDS after lung surgery. Chest. 1994;105(6):1642-1645. (Pubitemid 24180643)
20. Yamada K, Ikehara M, Tanaka G, Nomura I, Oshita F, Noda K. Dose escalation study of paclitaxel in combination with fixed-dose irinotecan in patients with advanced non-small cell lung cancer (JCOG 9807). Oncology. 2004;66(2):94-100. (Pubitemid 38608375)
21. Trisolini R, Lazzari Agli L, Tassinari D, et al. Acute lung injury associated with 5-fluorouracil and oxaliplatinum combined chemotherapy. Eur Respir J. 2001;18(1):243-245. (Pubitemid 32717453)
22. Jehn U, Göldel N, Rienmüller R, Wilmanns W. Non-cardiogenic pulmonary edema complicating intermediate and high-dose Ara C treatment for relapsed acute leukemia. Med Oncol Tumor Pharmacother. 1988;5(1):41-47.
23. Andersson BS, Luna MA, Yee C, Hui KK, Keating MJ, McCredie KB. Fatal pulmonary failure complicating high-dose cytosine arabinoside therapy in acute leukemia. Cancer. 1990;65(5):1079-1084. (Pubitemid 20072037)